Evidence map›Paper›PMID 29300777›Full record

ArticlePLoS pathogens2018

Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice.

Hui Li, Konrad C Bradley, Jason S Long, Rebecca Frise, Jonathan W Ashcroft, Lorian C Hartgroves, Holly Shelton, Spyridon Makris, Cecilia Johansson, Bin Cao and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Innate immune role of IL-6 in influenza a virus pathogenesis.Frontiers in cellular and infection microbiology · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Hallmarks of Severe COVID-19 Pathogenesis:Frontiers in immunology · 2022
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Hui LiChina-Japan Friendship Hospital, Capital Medical University, Beijing, China.
Konrad C BradleySection of Virology, Department of Medicine, Imperial College London, London, United Kingdom.
Jason S LongSection of Virology, Department of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0002-0251-6487
Rebecca FriseSection of Virology, Department of Medicine, Imperial College London, London, United Kingdom.
Jonathan W AshcroftSection of Virology, Department of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0002-6224-4233
Lorian C HartgrovesSection of Virology, Department of Medicine, Imperial College London, London, United Kingdom.
Holly SheltonSection of Virology, Department of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0002-5776-0735
Spyridon MakrisSection of Respiratory Infections, National Heart and Lung Institute, Imperial College London.ORCID 0000-0001-9243-2369
Cecilia JohanssonSection of Respiratory Infections, National Heart and Lung Institute, Imperial College London.ORCID 0000-0002-6607-5000
Bin CaoDepartment of Respiratory Medicine, Capital Medical University; Center for Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China.
Wendy S BarclaySection of Virology, Department of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0002-3948-0895
Imperial College London · GBCapital Medical University · CNLung Institute · US

Funding

Biotechnology and Biological Sciences Research Council BB/K002465/1Biotechnology and Biological Sciences Research Council BBS/E/I/00007031Biotechnology and Biological Sciences Research Council BBS/E/I/00007034Wellcome Trust
6 · The paper itself

Abstract

The highly pathogenic avian influenza (HPAI) H5N1 influenza virus has been a public health concern for more than a decade because of its frequent zoonoses and the high case fatality rate associated with human infections. Severe disease following H5N1 influenza infection is often associated with dysregulated host innate immune response also known as cytokine storm but the virological and cellular basis of these responses has not been clearly described. We rescued a series of 6:2 reassortant viruses that combined a PR8 HA/NA pairing with the internal gene segments from human adapted H1N1, H3N2, or avian H5N1 viruses and found that mice infected with the virus with H5N1 internal genes suffered severe weight loss associated with increased lung cytokines but not high viral load. This phenotype did not map to the NS gene segment, and NS1 protein of H5N1 virus functioned as a type I IFN antagonist as efficient as NS1 of H1N1 or H3N2 viruses. Instead we discovered that the internal genes of H5N1 virus supported a much higher level of replication of viral RNAs in myeloid cells in vitro, but not in epithelial cells and that this was associated with high induction of type I IFN in myeloid cells. We also found that in vivo during H5N1 recombinant virus infection cells of haematopoetic origin were infected and produced type I IFN and proinflammatory cytokines. Taken together our data infer that human and avian influenza viruses are differently controlled by host factors in alternative cell types; internal gene segments of avian H5N1 virus uniquely drove high viral replication in myeloid cells, which triggered an excessive cytokine production, resulting in severe immunopathology.

Indexed as

A549 CellsAnimalsCells, CulturedDogsFemaleGenes, ViralHEK293 CellsHumansImmunity, InnateInfluenza A Virus, H5N1 SubtypeInfluenza, HumanMadin Darby Canine Kidney CellsMiceMice, Inbred BALB CMice, Inbred C57BLMice, Knockout

Identifiers

PMID29300777
PMCPMC5771632
OpenAlexW2782500501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.